Pulsed Radiofrequency for Frozen Shoulder Chronic Pain (PRFFSCP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03456531|
Recruitment Status : Not yet recruiting
First Posted : March 7, 2018
Last Update Posted : March 7, 2018
|Condition or disease||Intervention/treatment||Phase|
|Frozen Shoulder||Device: pulsed radiofrequency Drug: NSAIDs "ibubrofen,Aspirin"||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Intervention Model Description:||prospective randomized clinically controlled study .|
|Masking:||None (Open Label)|
|Official Title:||Effect of Pulsed Radiofrequency to the Suprascapular Nerve in Treating Frozen Shoulder Pain|
|Estimated Study Start Date :||March 15, 2018|
|Estimated Primary Completion Date :||March 1, 2019|
|Estimated Study Completion Date :||March 1, 2020|
Active Comparator: group 1
20 patients will receive pulsed radiofrequency for 6 minutes to suprascapular nerve
Device: pulsed radiofrequency
The patient will have pulsed radiofrequency to suprascapular nerve for 6 minutes
Other Name: PRF
Placebo Comparator: group 2
20 patients will receive their medical treatment in the form of NSAIDs "ibubrofen,Aspirin"
Drug: NSAIDs "ibubrofen,Aspirin"
medical treatment as NSAIDs "ibubrofen,Aspirin"
Other Name: Analgesics
- pain measure [ Time Frame: 1 week ]to evaluate the efficacy of pulsed radiofrequency lesioning to the suprascapular nerve in treating pain in frozen shoulder using numeric pain rating scale where 0 is no pain and 10 is the worst pain ever
- Range of motion of the shoulder [ Time Frame: 3 months ]evaluate patient range of motion after the intervention using the simple shoulder test "by answering 12 questions "
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03456531
|Contact: yasmeen elmasry, RDemail@example.com|
|Study Director:||ayman othman, proffessor||Assiut univerisity|